The Impact of COVID-19 on Diabetic Retinopathy Monitoring and Treatment

PURPOSE OF REVIEW: Diabetic retinopathy (DR) is one of the leading causes of vision loss worldwide. Although screening and early treatment guidelines for DR have significantly reduced the disease burden, restrictions related to the COVID-19 pandemic have changed real-world practice patterns in the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Ishrat, Liu, T. Y. Alvin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Microvascular Complications—Retinopathy (R Channa, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425316/
https://www.ncbi.nlm.nih.gov/pubmed/34495377
http://dx.doi.org/10.1007/s11892-021-01411-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425316/
https://www.ncbi.nlm.nih.gov/pubmed/34495377
http://dx.doi.org/10.1007/s11892-021-01411-6

Ejemplares similares